Overview Weekly TP-HDFL in the Treatment of Advanced TCC Status: Completed Trial end date: 2004-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy of Weekly TP-HDFL in advanced transitional cell carcinoma in terms of response rate and overall survival. Phase: Phase 2 Details Lead Sponsor: National Taiwan University HospitalTreatments: Albumin-Bound PaclitaxelCisplatinFluorouracilPaclitaxel